LYVE1 antibody (AA 24-232)
Quick Overview for LYVE1 antibody (AA 24-232) (ABIN2745542)
Target
See all LYVE1 AntibodiesReactivity
Host
Clonality
Conjugate
Application
-
-
Binding Specificity
- AA 24-232
-
Purpose
- anti-LYVE-1 (human), pAb
-
Specificity
- Recognizes human LYVE-1.
-
Characteristics
- Polyclonal Antibody. Recognizes human LYVE-1. Source: Rabbit. Applications: FACS, IHC, WB. Lyophilized. LYVE-1 has been identified as a major receptor for HA (extracellular matrix glycosaminoglycan hyaluronan) on the lymph vessel wall. Like CD44, the LYVE-1 Molecule binds both soluble and immobilized HA. However, unlike CD44, the LYVE-1 Molecule colocalizes with HA on the luminal face of the lymph vessel wall and is completely absent from blood vessels. Hence, LYVE-1 is the first lymph-specific HA receptor to be characterized and is a uniquely powerful marker for lymph vessels themselves.
-
Purification
- Protein A purified.
-
Immunogen
- Recombinant human LYVE-1 (aa24-232).
-
-
-
-
Application Notes
- Optimal working dilution should be determined by the investigator.
-
Restrictions
- For Research Use only
-
-
-
Format
- Lyophilized
-
Reconstitution
- Centrifuge vial prior to opening. Reconstitute with sterile water to a concentration of 0.1-1.0 mg/mL.
-
Buffer
- Lyophilized.
-
Handling Advice
- After opening, prepare aliquots and store at -20 °C.Avoid freeze/thaw cycles.
-
Storage
- 4 °C,-20 °C
-
Storage Comment
-
+4°C
-20°C
Stable for at least 6 months after receipt when stored at -20°C.
-
Expiry Date
- 6 months
-
-
- LYVE1 (Lymphatic Vessel Endothelial Hyaluronan Receptor 1 (LYVE1))
-
Alternative Name
- Lyve1
-
Background
-
Alternate Names/Synonyms: Lymphatic Vessel Endothelial Hyaluronic Acid Receptor 1, CRSBP-1
Product Description: LYVE-1 has been identified as a major receptor for HA (extracellular matrix glycosaminoglycan hyaluronan) on the lymph vessel wall. Like CD44, the LYVE-1 Molecule binds both soluble and immobilized HA. However, unlike CD44, the LYVE-1 Molecule colocalizes with HA on the luminal face of the lymph vessel wall and is completely absent from blood vessels. Hence, LYVE-1 is the first lymph-specific HA receptor to be characterized and is a uniquely powerful marker for lymph vessels themselves.
-
UniProt
- Q9Y5Y7
-
Pathways
- Glycosaminoglycan Metabolic Process
Target
-